Search research articles
Contact Us
Filters
Showing results (231-240 of 268) with videos related to
Page
of 27
Sort By:
The Journal of Biological Chemistry
|
June 8, 2007
Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B
Lisa I Påhlman, Pauline F Marx, Matthias Mörgelin, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor
Pauline F Marx, Stefan R Havik, J Arnoud Marquart, et al.
AJNR. American Journal of Neuroradiology
|
April 16, 2002
Cardiovascular effects of polymethylmethacrylate use in percutaneous vertebroplasty
Timothy J Kaufmann, Mary E Jensen, Gabriele Ford, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2005
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors
A Gils, E Ceresa, A M Macovei, et al.
The Histochemical Journal
|
February 1, 1993
The effects of storage on the retention of enzyme activity in cryostat sections. A quantitative histochemical study on rat liver
W M Frederiks, I J Ouwerkerk, K S Bosch, et al.
Annals of the Rheumatic Diseases
|
June 16, 2009
Thrombin-activatable fibrinolysis inhibitor and its relation with inflammation in rheumatoid arthritis
M J L Peters, M T Nurmohamed, I C van Eijk, et al.
AJNR. American Journal of Neuroradiology
|
December 6, 2001
Elastase-induced saccular aneurysms in rabbits: comparison of geometric features with those of human aneurysms
J G Short, N H Fujiwara, W F Marx, et al.
Neuroradiology
|
June 29, 2000
Needle diameter in outpatient myelography: rates of adverse effects and current practice trends
R J Woodcock, W F Marx, R M Johnson, et al.
Thrombosis and Haemostasis
|
August 2, 2023
Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior
Joost C M Meijers, Johanneke van der Harst, Pauline F Marx, et al.
The Journal of Biological Chemistry
|
April 25, 2000
Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage
P F Marx, T M Hackeng, P E Dawson, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 268) with videos related to
Sort By:
Page
of 27
The Journal of Biological Chemistry
|
June 8, 2007
Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B
Lisa I Påhlman, Pauline F Marx, Matthias Mörgelin, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Generation and characterization of a highly stable form of activated thrombin-activable fibrinolysis inhibitor
Pauline F Marx, Stefan R Havik, J Arnoud Marquart, et al.
AJNR. American Journal of Neuroradiology
|
April 16, 2002
Cardiovascular effects of polymethylmethacrylate use in percutaneous vertebroplasty
Timothy J Kaufmann, Mary E Jensen, Gabriele Ford, et al.
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2005
Modulation of TAFI function through different pathways--implications for the development of TAFI inhibitors
A Gils, E Ceresa, A M Macovei, et al.
The Histochemical Journal
|
February 1, 1993
The effects of storage on the retention of enzyme activity in cryostat sections. A quantitative histochemical study on rat liver
W M Frederiks, I J Ouwerkerk, K S Bosch, et al.
Annals of the Rheumatic Diseases
|
June 16, 2009
Thrombin-activatable fibrinolysis inhibitor and its relation with inflammation in rheumatoid arthritis
M J L Peters, M T Nurmohamed, I C van Eijk, et al.
AJNR. American Journal of Neuroradiology
|
December 6, 2001
Elastase-induced saccular aneurysms in rabbits: comparison of geometric features with those of human aneurysms
J G Short, N H Fujiwara, W F Marx, et al.
Neuroradiology
|
June 29, 2000
Needle diameter in outpatient myelography: rates of adverse effects and current practice trends
R J Woodcock, W F Marx, R M Johnson, et al.
Thrombosis and Haemostasis
|
August 2, 2023
Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior
Joost C M Meijers, Johanneke van der Harst, Pauline F Marx, et al.
The Journal of Biological Chemistry
|
April 25, 2000
Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage
P F Marx, T M Hackeng, P E Dawson, et al.
Page
of 27